and ERK5 are activated via various hemodynamic forces, such as cyclic strain 8 and shear stress. 9 ERK5, the most recent member of MAPK family, has been evidenced to play a vital role in the mechanism of atheroprotective effects under sustained laminar flow that upregulates ERK5 activity. 6 However, ERK5 expression is increased in atherogenic prone regions in mice, and comparison of the atheroprone region with the atheroprotected region showed no obvious difference in ERK5 subcellular localization. 10 To evaluate this further, we investigated ERK5 activation and levels under different flow conditions, whether disturbed flow, continuous laminar flow (CLF), or pulsatile forward flow to determine whether spatial and temporal shear stress regulated ERK5 activation. We hypothesize that ERK5 activation in pulsatile uniform flow and CLF, but not in disturbed flow, as it is an atherogenic flow condition.
Materials and Methods

Cell Culture
Primary cultures of human umbilical vein endothelial cells (HUVECs) (obtained from the laboratory of Dr. Jordan Pober, Department of Pathology, Yale School of Medicine) were cultured with M-199 medium enriched with 20% fetal bovine serum (FBS; Gemini Bio-Products, West Sacramento, CA), 10 μg/mL heparin, 50 μg/mL EC growth supplement (BD Biosciences, Bedford, MA), and penicillin-streptomycin antibiotic combination (both 100 μg/mL), in a 5% CO 2 incubator at 37°C. After reaching confluence, 0.25% trypsin ethylene diamine tetra acetic acid was used for detachment, and passage 3 to 5 cells were seeded on fibronectin (BD Biosciences) coated glass slides (7 Â 38 mm, Fisher Scientific, Pittsburgh, PA). After reaching confluence, HUVECs were serum-starved (SS) in 1% FBS media for 2 hours prior to experimentation. Before the experiment, cells were rinsed free of culture medium with HEPES-buffered saline solution (130 mmol/L NaCl, 5 mmol/L KCl, 1.5 mmol/L CaCl 2 , 1.0 mmol/L MgCl 2 , and 20 mmol/L HEPES, pH 7.4). This study was approved by the institutional review board.
Mechanical Stress Exposure
Serum-starved HUVECs were exposed to shear stress for 30 minutes, 1 hour, 2 hours, or 4 hours under different flow conditions utilizing a parallel-plate flow chamber system (Cytodyne, San Diego, CA), as previously described.
11,12
Flow of the perfusion medium (M199 and 1% FBS) was regulated by a computer-controlled syringe pump (PHD 2000 and PHD Ultra Programmable, Harvard Apparatus, Holliston, MA). To generate PFF, an automated switch clamp (Auto-Fill valve box, Harvard Apparatus) is placed between the syringe pump and the flow chamber and between the syringe pump and the culture medium reservoir. Synchronous activation of both switch clamps with the cycle allows unidirectional flow. In TFF model, the switch clamp was not used, thus creating a form of disturbed flow. The flow chambers were directly attached to the flow loop circuit including the flow reservoir, which enabled culture medium in the flow chamber to be exchanged by every to-fro impulse. Approximately 1/10th of the culture media in the flow chamber was exchanged at least every 1 second. The shear stresses were 60 cycles per minute (cpm) of PFF, that is, a forward square wave impulse for 0.5 second alternating with no flow for 0.5 second; 60 cpm of TFF, that is, a forward square wave impulse for 0.5 second alternating with a backward square wave impulse for 0.5 second. CLF setup is a perfusion medium circulated in Norprene tubing (Masterflex, Court Vernon Hills, IL) using a roller pump to parallel plate flow chambers placed in the circuit. Small pulsations produced by the roller pump were dampened because of the long length of the tubing. The magnitude of shear was kept constant at 14 dyne/cm 2 for all flow conditions. Each experiment was repeated at least three times.
Immunoblot for ERK5
After experimentation, cells were washed in ice-cold PBS (Hyclone, South Logan, UT) twice and scraped in RIPA lysis buffer containing 1 mM PMSF, 1% SDS, 2 mM sodium orthovanadate, cocktail of phosphatase inhibitor I and II (EMD4 Bioscience, San Diego, CA), and protease inhibitor (Roche Applied Science, Indianapolis, IN). Cell lysates were centrifuged for 15,000 g for 10 minutes, and supernatants were collected. Protein content was measured by Bio-Rad protein assay system (Bio-Rad, Hercules, CA). Laemmli sample buffer was added to equal amounts of each sample, and samples were boiled for 5 minutes. Samples were resolved on 10% SDS-PAGE, which were separate blots for total ERK5 and pERK5, and transferred to polyvinylidene fluoride membrane. The membranes were probed with phosphorylated (P-ERK5 and ERK5 (Cell Signaling Technology, Danvers, MA) as the primary antibody. P-ERK5 antibody was incubated in 10% BSA and 5% milk. Rabbit secondary antibody (Cell Signaling Technology, Danvers, MA) was added, as suggested by the manufacture, and detected using chemiluminescence (Lumiglo, Cell Signaling Technology, Danvers, MA). Membranes were developed on ChemiDoc MP Imager (Bio-Rad, Hercules, CA), and quantification of bands was performed by densitometric analysis using Image J software (http://rsbweb.nih. gov/ij/). Densitometric data were expressed as the fold induction compared with the static control level.
Statistics
Calculation of the densitometric mean AE standard error of the mean of multiple experiments and statistical analysis utilizing ANOVA (analysis of variance) and post hoc test were performed using Minitab (State College, PA). A p value of < 0.05 was considered significant.
Results
Changes in ERK5 Levels when Exposed to Different Flow Conditions
ERK5 levels significantly decreased after 30 minutes of exposure to TFF compared with static conditions (n ¼ 3).
However, ERK5 levels did not change when exposed to CONT or PFF flow conditions after 30 minutes of stimulation (►Fig. 1). ERK5 levels decreased to 53.3% in TFF conditions (►Fig. 1C). After 1 hour of stimulation, ERK5 levels decreased in CONT, PFF, or TFF flow conditions (n ¼ 3) compared with static conditions (►Fig. 2). ERK5 levels decreased in CONT to 74.9%, PFF to 69.6%, and TFF to 53.3% compared with static conditions (►Fig. 2C). On longer duration of experiments, all flow conditions exhibited decreased ERK5 levels compared with static conditions after 2 hours of stimulation (►Fig. 3). ERK5 levels decreased in CONT to 49.5%, PFF to 65.7%, and TFF to 45.6% (n ¼ 6) compared with static conditions (►Fig. 3C). Also, after 4 hours of stimulation, ERK5 levels maintained a sustained decrease in all flow conditions (►Fig. 4). ERK5 levels decreased in CONT to 48.6%, PFF to 55.8%, and TFF to 44.6% (n ¼ 4) compared with static conditions (►Fig. 4C).
Significant Differences in ERK5 Level among Different Flow Conditions within Same Time Point
There were differences in reduction in ERK5 levels between all flowconditionsaftereachtimepointexperiment(►Fig.5).ERK5 levels decreased more in TFF than in CONT flow conditions after 30 minutes of exposure (ANOVA test, p < 0.05). After 1 hour of stimulation, there was no change in reduction in ERK5 levels between the different flow conditions. However, after 2 hours of stimulation, PFF exhibited least decrease in levels much lower comparedwithTFFand CONT flowconditions. Also,after4 hours of stimulation, TFF decreased compared with CONT and PFF. There was no statistical significance between different time point experiments within same or different flow conditions.
ERK5 Activation in Different Flow Conditions
There was no activation of ERK5 levels in all flow conditions for up to 1 hour of stimulation (n ¼ 3). Hydrogen peroxide stimulation served as a positive control whereas static conditions served as negative controls (►Fig. 1A, 2A). However, after 2 hours of activation, compared with static conditions, ERK5 is significantly activated in CONT, PFF, and TFF flow conditions (►Fig. 2A), and it exhibits a 2.2-, 2.7-, and 2.4-fold increase (►Fig. 2B). Static conditions and hydrogen peroxide, known to be a short-time activator of ERK5, served as negative controls. 13 After 4 hours of stimulation, only CONT and TFF conditions were significantly activated (►Fig. 4A).
CONT and TFF exhibited a 1.8-and 2-fold increase, respectively, whereas PFF did not exhibit any significant activation (►Fig. 4B). P-ERK5 levels in PFF conditions significantly decreased from 2 to 4 hours of stimulation compared with CONT, PFF, and TFF flow conditions. Also, after 4 hours of stimulation P-ERK5 levels is significantly low compared with TFF and CONT (►Fig. 5B).
Discussion
Laminar flow activates MEK5/ERK5 pathway in ECs, which results in an overall protective phenotype characterized by increased apoptosis resistance and a decreased angiogenic, migratory, and proinflammatory potential. 9,10,14-18 However, ERK5 also mediates noxious pathways, such tumor genesis and proinflammatory pathways. 19, 20 Although ectopic expression of ERK5 in the prostate cancer cell line PC3 increased proliferation, RNAi knockdown did not decrease proliferation. This suggests that the role of ERK5 in sustaining the proliferative signal may be cancer-cellline-or tumor-specific, and at this time, it is unknown what makes a cancer cell sensitive to ERK5 inhibition. 21 This known association of ERK5 with sustain proliferative signaling coincidences with the MEK5/ERK5 cascade has been shown to protect cells from apoptotic stimuli. 22 Furthermore, both MEK5 and ERK5 knockout mice rapidly die due to disruption of the vascular integrity. [23] [24] [25] Previous studies have demonstrated that ERK5 plays an essential role in the ability of shear stress to prevent EC apoptosis and plays a key role in flow-mediated anti-inflammatory effects.
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Our observation of ERK5 activation in CLF conditions is a validated observation based on previous studies. 17, 18 However, the ERK5 levels change in different flow conditions, and This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.
ERK5 activation in disturbed flow and transit activation in PFF has not been shown before. As these flow conditions, CLF and disturbed flow, are not natural physiologic flow conditions that EC cells are accustomed to, this observation further illustrates that disturbed flow is an apoptotic stimulus requiring ERK5 activation. Also, previous experiments have shown that ERK5 is activated in other apoptotic conditions such as high concentration hydrogen peroxide concentration. 26 However, whether activation of ERK5 by CLF has the same MEK5/ERK5 cascade as disturbed flow requires further analysis. It has been shown that the ERK5 cascade in ECs exposed to disturbed flow in vivo is different from exposure to laminar flow, in which disturbed flow-induced SUMOylation of proteins, including p53 and ERK5 occurs and is thought to be important in atherosclerosis formation.
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Further experiments are required to explain the observation of ERK5 level changes in different flow conditions. Our hypothesis is structural changes, or ubiquitination of ERK5 under these conditions may have caused these observations. It has been observed that in vivo studies ERK5 levels are increased in atherogenic areas of the vasculature compared with areas exposed to laminar flow.
10 Our in vitro model has shown differences of ERK5 levels among different flow conditions. Further studies are required to identify the causation of increase in ERK5 levels in vivo under disturbed flow whereas ERK5 levels decrease in vitro under the same flow condition. Our hypothesis is that in vivo conditions cells are not serum-starved and are able to replenish ERK5 levels whereas in vitro they are incapable to do so, and thus levels decrease. The phenomena of temporal and spatial components of shear stress may have independent or interposing effects; for example, low steady shear stress is the major impetus for differential gene expression and cell proliferation, whereas disturbed flow regulates monocyte adhesion. 28 Thus, further experiments are required to identify the different components of shear stress independent effects and its signaling pathway.
Conclusion
In our study, different patterns of flow induce decrease in ERK5 levels with the most decrease in TFF. ERK5 is an atheroprotective molecule that under uniform flow conditions induces downstream anti-inflammatory and antimigratory effects on ECs. However, disturbed flow induces ERK5 dysfunction. Our findings may aid to decipher in the understanding of the progression of atherosclerosis. Further studies investigating ERK-5 effect on intranuclear gene expression are required.
